<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, d...

    Rigel Pharmaceuticals, Inc. is a biotechnology ...

    Filing Type:    PU
    PAVmed Inc.

    PAVmed Inc.

    PAVmed Inc. is a highly differentiated, multiproduct medical device company employ...

    PAVmed Inc. is a highly differentiated, multipr...

    Filing Type:    PU
    IDEXX Laboratories, Inc.

    IDEXX Laboratories, Inc.

    IDEXX Laboratories, Inc. is a member of the S&P 500ÂŽ Index and is a leader in pet...

    IDEXX Laboratories, Inc. is a member of the S&P...

    Filing Type:    PU
    Nabriva Therapeutics plc

    Nabriva Therapeutics plc

    Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in th...

    Nabriva Therapeutics is a commercial-stage biop...

    Filing Type:    PU
    Gamida Cell Ltd.

    Gamida Cell Ltd.

    Gamida Cell is a clinical-stage biopharmaceutical company committed to developing ...

    Gamida Cell is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Proteon Therapeutics, Inc.

    Proteon Therapeutics, Inc.

    Proteon Therapeutics is working to deliver a new future for patients and families ...

    Proteon Therapeutics is working to deliver a ne...

    Filing Type:    PU
    CytoDyn Inc.

    CytoDyn Inc.

    CytoDyn is a publicly traded late stage biotechnology company developing innovativ...

    CytoDyn is a publicly traded late stage biotech...

    Filing Type:    PU
    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc. (“Checkpoint”) is a clinical-stage, immuno-oncol...

    Checkpoint Therapeutics, Inc. (“Checkpoint”...

    Filing Type:    PU
    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on th...

    G1 Therapeutics, Inc., is a clinical-stage biop...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.